Citigroup Boosts AbbVie (NYSE:ABBV) Price Target to $205.00
AbbVie (NYSE:ABBV – Get Free Report) had its price objective hoisted by research analysts at Citigroup to $205.00 in a report issued on Wednesday, Stock Target Advisor reports. The firm presently has a “hold” rating on the stock. Citigroup’s price target points to a potential upside of 6.62% from the company’s previous close. A number […]
AbbVie (NYSE:ABBV – Get Free Report) had its price objective hoisted by research analysts at Citigroup to $205.00 in a report issued on Wednesday, Stock Target Advisor reports. The firm presently has a “hold” rating on the stock. Citigroup’s price target points to a potential upside of 6.62% from the company’s previous close. A number […]
